Discover 658 paid clinical trials in Austin. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Sponsor:
VistaGen Therapeutics, Inc.
Location:
Code:
NCT06615557
Conditions
Social Anxiety Disorder (SAD)
Eligibility Criteria
Sex: All
Age: 18 - 65
Healthy Volunteers: Not accepted
Interventions
Fasedienol Nasal Spray
Placebo Nasal Spray
Sponsor:
OncoResponse, Inc.
Location:
Code:
NCT06090266
Conditions
Cancer
Tumor, Solid
Malignant Neoplasm
Metastatic Cancer
Advanced Solid Tumor
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
OR502
Cemiplimab
Sponsor:
AstraZeneca
Location:
Code:
NCT06283966
Conditions
COPD (Chronic Obstructive Pulmonary Disease)
Eligibility Criteria
Sex: All
Age: 40 - 70+
Healthy Volunteers: Not accepted
Interventions
BGF MDI 320/14.4/9.6 μg
GFF MDI 14.4/9.6 μg
Sponsor:
Neumora Therapeutics, Inc.
Location:
Code:
NCT06029426
Conditions
Major Depressive Disorder
Eligibility Criteria
Sex: All
Age: 18 - 65
Healthy Volunteers: Not accepted
Interventions
NMRA-335140
Placebo
Sponsor:
AstraZeneca
Location:
Code:
NCT06268873
Conditions
Chronic Kidney Disease and Hypertension
Eligibility Criteria
Sex: All
Age: 18 - 70+
Healthy Volunteers: Not accepted
Interventions
Baxdrostat/dapagliflozin
Dapagliflozin in combination with placebo
Sponsor:
Priovant Therapeutics, Inc.
Location:
Code:
NCT06431373
Conditions
Uveitis, Posterior
Uveitis, Intermediate
Uveitis
Eligibility Criteria
Sex: All
Age: 18 - 70+
Healthy Volunteers: Not accepted
Interventions
Brepocitinib PO QD
Placebo PO QD
Sponsor:
Allogene Therapeutics
Location:
Code:
NCT06500273
Conditions
Large B-cell Lymphoma
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
cemacabtagene ansegedleucel
ALLO-647
Fludarabine
Cyclophosphamide
Foresight CLARITY™ IUO MRD test, powered by PhasED-Seq™
Sponsor:
BioNTech SE
Location:
Code:
NCT04813627
Conditions
Colorectal Cancer Stage II
Colorectal Cancer Stage III
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Regular blood sample collection for ctDNA assessment
Sponsor:
MacroGenics
Location:
Code:
NCT05362773
Conditions
Leukemia, Acute Myeloid
Myelodysplastic Syndromes
Classical Hodgkin Lymphoma
Leukemia, B-cell
Leukemia, Hairy Cell
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
MGD024
Sponsor:
Pfizer
Location:
Code:
NCT04173273
Conditions
Crohn's Disease
Eligibility Criteria
Sex: All
Age: 18 - 70+
Healthy Volunteers: Not accepted
Interventions
Etrasimod
Placebo
With a dynamic healthcare network and prominent research institutions, Austin is a significant hub for clinical trials. Key organizations like the Dell Medical School at the University of Texas at Austin, the Texas Diabetes Institute, and the Austin Cancer Center are leading advancements in medical research. These institutions are at the forefront of clinical studies, driving innovation across various fields and contributing to groundbreaking treatments and healthcare solutions.
Austin, Texas, provides distinct advantages for those participating in clinical trials. The city’s vibrant and diverse population offers a rich pool of participants, enhancing the accuracy and applicability of research findings. Austin is renowned for its innovative medical research environment, driven by leading institutions that focus on pioneering advancements and cutting-edge studies.
By joining a clinical trial in Austin, participants not only contribute to significant medical research but also benefit from a highly collaborative and supportive clinical research ecosystem. The city’s commitment to advancing healthcare through research ensures that participants are involved in meaningful studies that push the boundaries of medical science.
In Austin, clinical trials address a broad spectrum of medical conditions, reflecting the city’s commitment to advancing healthcare through innovative research and specialized facilities.
Austin is a leading hub for diabetes research, with institutions such as the Texas Diabetes Institute and Dell Medical School conducting extensive trials. These studies focus on developing new insulin formulations, advanced glucose monitoring technologies, and innovative treatments aimed at both Type 1 and Type 2 diabetes.
Trials often explore combination therapies that integrate lifestyle changes, diet modifications, and cutting-edge pharmaceuticals to optimize glycemic control and enhance quality of life for patients.
The Austin Cancer Center and Dell Medical School are prominent in the field of oncology, with clinical trials investigating a range of cancers including breast, prostate, and lung cancer.
These trials are at the forefront of exploring new immunotherapies, which harness the body’s immune system to target cancer cells more effectively, and targeted therapies that focus on specific genetic mutations. Additionally, cancer clinical trials often test new combinations of chemotherapy, radiation, and emerging drug therapies to improve treatment efficacy and reduce side effects.
Neurological research in Austin is concentrated on conditions such as Alzheimer’s disease, Parkinson’s disease, and multiple sclerosis (MS). Clinical trials frequently involve testing novel drug treatments aimed at slowing disease progression, exploring new biomarkers for early diagnosis, and utilizing advanced imaging techniques to better understand disease mechanisms.
Trials may also assess the effectiveness of non-pharmacological interventions, including cognitive therapies and rehabilitation approaches.
Austin’s clinical trials in cardiovascular research target a variety of conditions including hypertension, heart failure, and coronary artery disease. Studies often focus on the development of new pharmacological treatments, innovative surgical techniques, and preventive strategies to manage risk factors.
Cardiovascular clinical trials might also explore the use of new drug classes, such as novel anticoagulants or lipid-lowering agents, as well as minimally invasive procedures like catheter-based interventions and improvements in cardiac imaging.
Clinical trials in Austin also address autoimmune diseases such as rheumatoid arthritis, hidradenitis suppurativa and lupus. Research here investigates new biologic therapies that specifically target immune system components involved in disease pathology, as well as other immune-modulating treatments. Trials often explore the efficacy of these new treatments in reducing inflammation, managing symptoms, and improving overall disease management.
In Austin, clinical trials are governed by a comprehensive set of regulations ensuring ethical conduct and participant safety. Researchers must adhere to federal guidelines from the FDA and HHS, including compliance with Title 21 of the Code of Federal Regulations, which covers aspects like informed consent, IRB approval, and Good Clinical Practice.
Institutional Review Boards (IRBs) are responsible for reviewing and approving study protocols to ensure they meet ethical standards and protect participants. Additionally, Texas state regulations, overseen by the Texas Medical Board and Health and Human Services Commission, complement federal requirements. Trials must also comply with HIPAA to safeguard participant privacy and data.
Volunteering in a clinical trial provides the exclusive opportunity to access innovative treatments and therapies ahead of their general release. Participants in a clinical trial will receive specialized care from leading healthcare professionals who offer personalized attention and detailed monitoring throughout the research.
Involvement in clinical trials is essential for advancing medical science and can result in important breakthroughs in both treatment and prevention. By taking part, individuals contribute significantly to the development of new medical knowledge, helping to enhance future healthcare outcomes for others.
Interested in participating in clinical trials but worried about how long they might take? Check out our comprehensive guide for all the information you need to make an informed decision.
Enrolling in a clinical trial through our platform is a straightforward and user-friendly process. Here's how to get started: